Immunoliposome-mediated drug delivery to Plasmodium-infected and non-infected red blood cells as a dual therapeutic/prophylactic antimalarial strategy

Different outcomes expected when antimalarial drugs are targeted (A) only to Plasmodium-infected erythrocytes, or (B) to all erythrocytes. In the latter case the parasite will encounter the drug upon invasion.230